Zacks.com on MSN2d
Moderna Stock Rises on Q3 Earnings & Sales Beat, Reiterates View
Moderna, Inc. MRNA reported earnings of 3 cents per share in the third quarter of 2024. The Zacks Consensus Estimate was a ...
Buy, Sell, Or Hold MRNA Stock?
The top-line beat was led by its higher than anticipated sales of Covid-19 vaccine, while its recently approved respiratory syncytial virus vaccine raked in just $10 ...
Moderna (MRNA) Q3 2024 Earnings Call Transcript
Welcome to the Moderna third quarter 2024 conference call. [Operator instructions] Please be advised today's conference is ...
Could mRNA vaccines conquer another deadly infection? Penn researchers say yes.
Working with animals, Penn researchers modified the mRNA vaccine to target C. difficile, an infection that kills 30,000 in ...
Moderna’s Mixed Performance: Strong Spikevax Sales Drive Q3 Success Amid mRESVIA Uncertainties, Resulting in Hold Rating
Moderna (MRNA – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Tyler Van Buren ...
Pfizer, GSK, Moderna struggle in a shrinking RSV vaccine market
Q3 results confirms that the U.S. vaccine market for respiratory syncytial virus (RSV), led by Pfizer (PFE) and GSK (GSK), is ...
Mixed Signals from Moderna’s Q3 2024 Performance: Hold Recommendation Issued
Needham analyst Joseph Stringer has maintained their neutral stance on MRNA stock, giving a Hold rating on October 28. Joseph Stringer has ...
New Study Reveals How Repeated mRNA Vaccines Boost Nasal Immunity Against COVID-19
Repeated mRNA vaccinations boost mucosal antibodies, improving defense against COVID-19. This may help enhance protection ...
DeSantis floats Florida surgeon general Dr. Joseph Ladapo as candidate for Trump's HHS secretary
Florida Gov. Ron DeSantis is advocating for President-elect Donald Trump to tap Florida Surgeon General Joseph Ladapo for the role of HHS secretary.
centerforbiosimilars5d
BioRationality: Should mRNA Copies Be Filed as NDAs or Biosimilars?
The article by Sarfaraz K. Niazi, PhD, argues that the FDA’s classification of future copies of messenger RNA (mRNA) products ...
Health Canada approves Moderna’s mRNA RSV vaccine, company says
Health Canada has approved Moderna’s mRNA vaccine to protect against respiratory syncytial virus in adults age 60 and older – ...
Moderna Reports Third Quarter 2024 Financial Results and Provides Business Updates
Moderna Chief Human Resources Officer Tracey Franklin has expanded her role to Chief People and Digital Technology Officer, overseeing the Company's talent and digital functions. Brad Miller, Chief ...